Clinical Trials
5 trialsNCT07511517 2026-04-09
BladMetrix
Oslo University Hospital
Active not recruiting
NCT05635266 2024-05-07
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
Recruiting
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT03847753 2020-05-22
COMO-GMC
University of Aarhus
Completed
NCT00670527 2012-10-08
PROPET
Odense University Hospital
Phase NA Unknown